Josep Llorens - Sep 7, 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: EVP, Global Manufacturing
Signature: /s/ Michelle Basil, attorney-in-fact for Mr. llorens
Stock symbol: HAE
Transactions as of: Sep 7, 2021
Transactions value $: -$6,461
Form type: 4
Date filed: 9/9/2021, 04:56 PM
Previous filing: May 20, 2021
Next filing: May 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Sale	-$6.46K	-100	-0.68%	$64.61	14.5K	Sep 7, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	This number includes unvested RSUs previously reported.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

This number includes unvested RSUs previously reported.